Patents by Inventor Wei-Guo Su

Wei-Guo Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
    Publication number: 20150368271
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: January 21, 2015
    Publication date: December 24, 2015
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS THEREOF
    Publication number: 20150307520
    Abstract: Disclosed are novel heteroaryl and heterocycle compounds of formula I-1, I-2 or I-3 and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune diseases and cancer.
    Type: Application
    Filed: July 26, 2013
    Publication date: October 29, 2015
    Inventors: Wei-Guo SU, Guangxiu DAI, Kun XIAO, Hong JIA, Zhulin ZHANG, Jennifer Diane VENABLE, Scott Damian BEMBENEK, Wenying CHAI
  • SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS
    Publication number: 20150307491
    Abstract: The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, L, m, p and W are as defined in the specification.
    Type: Application
    Filed: December 7, 2012
    Publication date: October 29, 2015
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo SU, Wei DENG
  • Quinazoline compounds
    Patent number: 9168253
    Abstract: Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: October 27, 2015
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS
    Publication number: 20150291593
    Abstract: Provided are novel heteroaryl and heterocycle compounds of formula (I-1), (I-2) or (I-3) and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune disorders diseases and cancer.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 15, 2015
    Inventors: Wei-Guo Su, Guangxiu Dai, Kun Xiao, Hong Jia, Jennifer Diane Venable, Scott Damian Bembenek, Wenying Chai
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 8987269
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: March 24, 2015
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
    Patent number: 8946249
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: February 3, 2015
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Hong Jia, Yumin Cui, Yongxin Ren, Yang Sai, Zhenping Wu, Wenji Li, Jiangyong Shao, Zhenping Tian
  • Pyrimidine derivatives
    Patent number: 8901143
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, T, U, V, X, Y, Z, G, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: December 2, 2014
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Weihan Zhang, Yumin Cui, Xiaoqiang Yan, Yongxin Ren, Jifeng Duan, Yang Sai
  • COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE
    Publication number: 20140200232
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Application
    Filed: December 12, 2013
    Publication date: July 17, 2014
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: WEI-GUO SU, WEIHAN ZHANG, HONG JIA, YUMIN CUI, YONGXIN REN, YANG SAI, ZHENPING WU, WENJI LI, JIANGYONG SHAO, ZHENPING TIAN
  • SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
    Publication number: 20140121200
    Abstract: Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
    Type: Application
    Filed: June 7, 2012
    Publication date: May 1, 2014
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jianguo Ji
  • Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
    Patent number: 8658658
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: February 25, 2014
    Assignee: Hutchison MediPharma Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Hong Jia, Yumin Cui, Yongxin Ren, Yang Sai, Zhenping Wu, Wenji Li, Jiangyong Shao, Zhenping Tian
  • PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20130210831
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Application
    Filed: August 18, 2011
    Publication date: August 15, 2013
    Inventors: Wei-Guo Su, Wei Deng, Jinshui Li, Jianguo Ji
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 8507487
    Abstract: Provided are certain triazolopyridines and triazolopyrazines of Formula 1. wherein X, Y, R1, R2, R3, R4 and R5 have any of the meanings described herein; processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: August 13, 2013
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Pyrimidinyl indole compounds
    Patent number: 8501166
    Abstract: The present invention provides pyrimidinyl indole compounds as novel kinase inhibitors for the treatment of cancer and inflammatory diseases.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: August 6, 2013
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Jinshui Li
  • Use of substituted quinazoline compounds in treating age-related macular degeneration
    Patent number: 8497372
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: July 30, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • QUINAZOLINE COMPOUNDS
    Publication number: 20130172373
    Abstract: Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).
    Type: Application
    Filed: May 25, 2011
    Publication date: July 4, 2013
    Applicant: Hutchison Medipharma Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • Quinazoline derivatives
    Patent number: 8426430
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, X, Y, and Z are defined herein. It also discloses a method of treating cancer with one of these compounds.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: April 23, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • PYRIMIDINYL INDOLE COMPOUNDS
    Publication number: 20130058892
    Abstract: The present invention provides pyrimidinyl indole compounds as novel kinase inhibitors for the treatment of cancer and inflammatory diseases.
    Type: Application
    Filed: April 27, 2010
    Publication date: March 7, 2013
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Jinshui Li
  • Pyrimidine derivatives
    Patent number: 8349859
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5, T, U, V, X, Y, Z, G, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: January 8, 2013
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Weihan Zhang, Yumin Cui, Xiaoqiang Yan, Yongxin Ren, Jifeng Duan, Yang Sai
  • COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE
    Publication number: 20120270889
    Abstract: Compound of Formula A and pharmaceutically acceptable salts thereof and crystalline Forms I and II of Compound of Formula A! Also, methods for the preparation of such compounds, pharmaceutical compositions comprising such compounds, and methods for their uses.
    Type: Application
    Filed: November 23, 2010
    Publication date: October 25, 2012
    Inventors: Wei-Guo Su, Weihan Zhang, Hong Jia, Yumin Cui, Yongxin Ren, Yang Sai, Zhenping Wu, Wenji Li, Jiangyong Shao, Zhenping Tian